Anti-CD20 (Research Grade Obinutuzumab Biosimilar) sinobiological 68055-H001

$714.00
In stock
SKU
68055-H001
Catalog No.SizePrice (USD)
68055-H001-55 mg$740.55
68055-H001-2525 mg$2,221.66
68055-H001-500500 µg$222.17

General Information

Product nameAnti-CD20 (Research Grade Obinutuzumab Biosimilar)
Species reactivityReacts with: Human
SpecificityCD20
PreparationThis product is a recombinant monoclonal antibody expressed from HEK293 cells.
SourceIgG1, Kappa
PurificationProtein A
FormulationHistidine and Arginine buffer containing 120mM NaCl, 0.02% Tween 80, pH6.0
ConjugateUnconjugated
Endotoxin≦ 1 EU/mg
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageAntibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Image / Experimental Information

Image 1 Description≥95 % as determined by SDS-PAGE.
Image 1 Alt TextHuman CD20-Obinutuzumab Enzyme linked immunosorbent assay (ELISA) 45953
Image 1 URLSource image
Image 2 Description≥95 % as determined by SDS-PAGE.
Image 2 Alt TextHuman CD20-Obinutuzumab Enzyme linked immunosorbent assay (ELISA) 45954
Image 2 URLSource image

title: A Pathologically Friendly Strategy for Determining the Organ-specific Spatial Tumor Microenvironment Topology in Lung Adenocarcinoma Through the Integration of snRandom-seq and Imaging Mass Cytometry.
authors: Xuqi Sun; Xiao Teng; ...; Xuanwen Bao
journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
date: 2024-04-29
pmid: 38682485
doi: 10.1002/advs.202308892
cited_by_count: 5
techniques: Amplification; Formalin-fixed Paraffin-Embedded; Imaging; Incubation; Staining
bioz_score: 92

title: Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells.
authors: Sara Cherradi; Véronique Garambois; ...; Maguy Del Rio
journal: Cell & bioscience
date: 2023-04-11
pmid: 37041570
doi: 10.1186/s13578-023-01015-5
cited_by_count: 13
techniques: Control; Cytometry; Cytotoxicity Assay; Fluorescence; Imaging; In Vitro; In Vivo; Incubation; Viability Assay
bioz_score: 92

title: Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient
authors: Xiao-Hong Yao; Zhi-Cheng He; ...; Xiu-Wu Bian
journal: Cell Research
date: 2020-04-28
pmid: 32346074
doi: 10.1038/s41422-020-0318-5
pmcid: 7186763
cited_by_count: 128
bioz_score: 92

title: Moving Forward: Recent Developments for the Ferret Biomedical Research Model
authors: Randy A. Albrecht; Wen-Chun Liu; ...; Thomas E. Morrison
journal: mBio
date: 2018-07-17
pmid: 30018107
doi: 10.1128/mBio.01113-18
pmcid: 6050969
cited_by_count: 48
techniques: Enzyme-linked Immunospot; Immunohistochemistry; Staining
bioz_score: 92

title: Influenza Virus
journal: Methods in Molecular Biology
date: 2018-01-01
doi: 10.1007/978-1-4939-8678-1
cited_by_count: 0
techniques: Cytometry; Diagnostic Assay; Enzyme-linked Immunosorbent Assay; Enzyme-linked Immunospot
bioz_score: 92

Reviews

Write Your Own Review
You're reviewing:Anti-CD20 (Research Grade Obinutuzumab Biosimilar) sinobiological 68055-H001
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.